Alternatively, activation of wild-type BRAF (BRAFWT) and CRAF can occur through activating mutations in NRAS, or KIT, or and through NF1 deletion [16], which occur in approximately 20% of melanomas [14]. This evidence concerns the gene NRAS and melanoma.